News

Nexxen International Set to Report Earnings Soon – What to Know

Nexxen International Set to Report Earnings Soon – What to Know

Understanding the Upcoming Earnings of Nexxen International

Nexxen International (NASDAQ:NEXN) is gearing up to release its most recent quarterly earnings report soon. Investors are curious about what this means for the company's future.

Forecasted Earnings Performance

Analysts are predicting that Nexxen International will announce an earnings per share (EPS) of $0.19. This projection has generated interest among investors who are keenly looking forward to the earnings call.

Market Reactions and Expectations

The market response leading up to this announcement has been filled with speculation. Investors are hoping for positive updates that go beyond the current estimates, which could result in a more optimistic outlook for the upcoming quarters.

Recap of Previous Earnings

An Insight into Past Earnings Releases

During the last earnings release, Nexxen exceeded EPS expectations by $0.13. However, this was followed by a 5.76% decrease in share price the next trading day, highlighting the unpredictable nature of market reactions.

Current Share Performance of Nexxen International

Stock Price Overview

As of November 11, shares of Nexxen International stood at $7.79. The 52-week data shows a slight decrease of 1.19%, indicating a challenging performance trend. Long-term investors may have a cautious outlook as the earnings announcement approaches.

Analyst Insights for Nexxen International

Understanding Market Sentiment

Diving into market analytics reveals the current consensus on Nexxen International. Analysts are leaning towards a Buy rating based on three recent evaluations, indicating trust in the stock's potential. The average target price is set at $15.00, suggesting a remarkable upside of over 92%.

Comparative Analysis with Industry Peers

Diving into Industry Comparisons

It’s beneficial to examine Nexxen's performance relative to competitors within the industry. Comparing Nexxen with other notable players offers insights into its standing and potential future growth.

  • PubMatic holds a Buy rating, with an average one-year price target of $15.40, indicating potential growth of 97.69%.
  • National CineMedia has an Outperform rating, but analysts expect a slight decline with a price target of $6.50, suggesting a potential downside of 16.56%.
  • Thryv Holdings is similarly rated with a Buy and a price target of $14.00, representing anticipated upside of 79.72%.

Summary of Peer Performance

Evaluating Key Metrics

To provide a comprehensive view, examining essential metrics reveals how Nexxen International compares against its competition. This analysis includes revenue growth and profit margins.

Nexxen International shines in revenue growth with a rate of 17.06%. Additionally, its gross profit exceeds $95.22 million, although the return on equity is relatively low at 4.71%. This combination of factors highlights Nexxen's performance relative to industry averages.

Getting to Know Nexxen International

Introduction to the Company

Nexxen International Ltd operates as a versatile advertising technology platform. With expertise in data-driven solutions and advanced TV capabilities, the company provides significant advantages to advertisers, agencies, and publishers. Nexxen is active in multiple global markets, particularly in America, contributing to most of its revenue.

A Closer Look at Financial Health

Analyzing Financial Metrics

Examining key financial metrics, we find Nexxen's market capitalization is below the industry average, potentially affecting investor perceptions. Nonetheless, the company showcases positive revenue growth and a strong net margin of 22.13%. The low debt-to-equity ratio of 0.07 further reflects a prudent approach to leveraging.

Frequently Asked Questions

When will Nexxen International report its earnings?

Nexxen International is expected to report its earnings soon, with specific dates subject to confirmation.

What is the predicted EPS for Nexxen International?

The estimated EPS for Nexxen is $0.19 according to analyst predictions.

How have Nexxen's shares performed recently?

Currently, Nexxen shares are trading at $7.79, reflecting a slight decline of 1.19% over the past year.

What is the consensus rating for Nexxen's stock?

The consensus rating among analysts for Nexxen International is Buy, indicating confidence in future growth.

How does Nexxen compare with its industry peers?

Nexxen outperforms some peers in revenue growth but ranks lower in terms of return on equity.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 321

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 237

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 443

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 22

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 254

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 238

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

FCPT Expands Portfolio with $3.5 Million Veterinary Acquisition

Updated Category News Views 166

FCPT's Recent Acquisition Highlights Strategic Growth Four Corners Property Trust (NYSE:FCPT) has recently made headlines by acquiring a National Veterinary Associates property for $3.5 million. This acquisition signifies a notable addition to their expanding portfolio, reflecting FCPT's commitment to strategically investing in quality real estate. Details of the...

Continue Reading
Impact of National Security Probe on RH Stock Performance

Updated Category News Views 137

Unveiling the Impact of Recent National Security Investigations Shares of luxury furniture retailer RH have taken a significant hit due to President Donald Trump's announcement of a national security probe into furniture imports. This scrutiny has raised concerns across the home furnishings industry, known for its heavy reliance on global supply chains. Key Takeaways from...

Continue Reading
Understanding the Trends in Constellation Brands' Short Interest

Updated Category News Views 207

Exploring Constellation Brands' Short Interest Constellation Brands, identified by the ticker STZ, has recently reported an increase in its short percent of float, now at 10.22% since the last analysis. The company's latest data shows a total of 7.48 million shares sold short. This figure constitutes 4.42% of all available regular shares for trading. With an analysis...

Continue Reading
CTL's New Modular Monitor Aims to Redefine Flexibility

Updated Category News Views 7

CTL Unveils Innovative Modular Desktop Solutions CTL's latest move in the tech world features a new set of modular desktop products designed to cater to the education, enterprise, and government sectors. Their fresh offering—the CTL MTIP24OPS 24" Open Pluggable Specification (OPS)-Ready Monitor—comes along with two All-in-One computers operating on ChromeOS. This...

Continue Reading
Franklin Universal Trust Declares Monthly Share Distribution

Updated Category News Views 143

Franklin Universal Trust Announces Monthly Distribution Franklin Universal Trust [NYSE: FT] has declared a monthly distribution of $0.0425 per share, aimed at shareholders who are on record. This distribution is derived from net investment income and is set to be paid in the near future. Investment Objectives of the Fund The primary investment goal of Franklin Universal...

Continue Reading